Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BioNTech SE

https://biontech.de/

Latest From BioNTech SE

TORL Looks To Break Ground In Growing Field Of Claudin-Targeting Drugs

The company announced a series B-2 financing of $158m that it plans to use for pivotal Phase II development of TORL-1-23, which it called a first-in-class agent.

Financing Business Strategies

Big Pharma Oncology Strategies Aim To Treat Cancer Earlier

ADCs, radiopharmaceuticals, precision medicines and T-cell engagers dominated R&D pipelines reviewed by 12 big pharmas at the first annual AACR Oncology Industry Partnering Event.

Cancer Strategy

Accessing Venture Debt From The EIB

Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.

Financing Europe

Quick And Flexible Vaccine Approval Must Include Postmarket Simplicity, US FDA’s Kaslow Says

After making the COVID-19 vaccines available, multiple presentations based on age and vaccination status created confusion that likely hindered uptake, said OVRR Director David Kaslow.

Vaccines Research & Development
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
  • Other Names / Subsidiaries
    • BioNTech US Inc.
    • Biopharmaceutical New Technologies AG
    • Neon Therapeutics, Inc.
    • BioNTech AG
UsernamePublicRestriction

Register